The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1971, 106: 324-333.
Copyright © 1971 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, K. R.
Right arrow Articles by Braude, A. I.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Brown, K. R.
Right arrow Articles by Braude, A. I.

Prevention of Death from Endotoxin with Antisera

II. Elimination of the Risk of Anaphylaxis to Endotoxin1

Kenneth R. Brown, Herndon Douglas and Abraham I. Braude

From the Department of Medicine, University of California-San Diego, School of Medicine, San Diego, California

Abstract

Fatal passive anaphylaxis to endotoxin was induced in mice given rat antiserum to endotoxin. In order to remove this dangerous property of antiserum, measures were taken to eliminate anaphylaxis and restore protection. Anaphylaxis to endotoxin was prevented by Isuprel, epinephrine and reserpine and by physicochemical alteration of the serum by dilution or UV irradiation. When anaphylaxis was avoided by any of these maneuvers, the antisera prevented death from endotoxin. Separation of immune globulin fractions on Sephadex columns also eliminated the anaphylactic property and the 19S and 7S fractions of immune serum prevented death from endotoxin. The observed anaphylaxis is thought to result from antigen-antibody complexes releasing vasoactive amines. Cytophilic antibody was not involved. This solution of the problem of passive anaphylaxis to endotoxin is an essential step in preparing a safe antiserum for preventing death from endotoxin in man.

Footnotes

1 This work was supported by United States Public Health Service Training Grant 5-T01 HE05467 and United States Army Contract DADA 17-67-C7026.




This article has been cited by other articles:


Home page
Innate ImmunityHome page
A.S. Cross and S. Opal
Minireview: Therapeutic intervention in sepsis with antibody to endotoxin: is there a future?
Innate Immunity, March 1, 1994; 1(1): 57 - 69.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1971 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1971 by The American Association of Immunologists, Inc. All rights reserved.